<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03154242</url>
  </required_header>
  <id_info>
    <org_study_id>PHCL137</org_study_id>
    <nct_id>NCT03154242</nct_id>
  </id_info>
  <brief_title>Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung Cancer</brief_title>
  <official_title>Effect of Genetic Polymorphisms on Clinical Outcome of Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Study evaluate the effect of Polymorphism in the Excision repair cross-complementing
      group 5 (ERCC5) (rs1047768 and rs751402) gene on the clinical outcome of Platinum-based
      regimens used in the treatment of Non-Small Cell Lung Cancer (NSCLC) patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Progression-free survival (PFS)</measure>
    <time_frame>From the date of starting the chemotherapy until the date of documented disease progression or date of death from any cause assessed up to 12 months</time_frame>
    <description>It's defined as the time from day 1 of chemotherapy to the day of documented disease progression or death from any cause.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Carcinoma, Non-Small-Cell Lung</condition>
  <eligibility>
    <study_pop>
      <textblock>
        clinical oncology department at Al Demerdash hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Newly diagnosed with immunohistochemically and pathologically confirmed non-small cell
             lung cancer (NSCLC).

          2. Eastern Cooperative Oncology Group performance status (ECOG PS) = 0-2.

          3. Chemotherapy na√Øve.

          4. Age &gt;18 years.

          5. Adequate bone marrow reserve

        Exclusion Criteria:

          1. Presence of Central nervous system(CNS) metastases.

          2. Inadequate liver function

          3. Inadequate renal function

          4. Serious comorbid systemic disorder incompatible with the study.

          5. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esraa S Abdalkhalek</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>demonstrator of clinical pharmacy</last_name>
    <phone>01151958437</phone>
    <email>esraa.salah@pharm.asu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Al Demerdash Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>May 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2017</study_first_posted>
  <last_update_submitted>May 13, 2017</last_update_submitted>
  <last_update_submitted_qc>May 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Esraa Salah Abdal Hay Abdal Khalek</investigator_full_name>
    <investigator_title>demonstrator of clinical pharmacy</investigator_title>
  </responsible_party>
  <keyword>non small cell lung cancer</keyword>
  <keyword>NSCLC</keyword>
  <keyword>Platinum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

